DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 2.17% to $24.30 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.74% to 17,844.24 and Dow Jones Industrial Average falling 0.24% to 41,218.83.
Catalyst Pharmaceuticals Inc. closed 7.10% below its 52-week high of $26.16, which the company reached on March 24th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.72% to $155.00, Pfizer Inc. $(PFE)$ fell 1.36% to $23.87, and Abbott Laboratories $(ABT)$ fell 0.17% to $132.60.
Trading volume (806,327) remained 528,011 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 5, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 05, 2025 17:25 ET (21:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。